Ask Us
Please correct the highlighted fields below.

Alerts for Omeprazole

Title Date Published Source
FDA Issues Safety Announcement: Proton Pump Inhibitors (PPIs) Possibly Associated with Clostridum Difficile-Associated Diarrhea (CDAD) 2012-02-08
Les Laboratoires BOUCHARA-RECORDATI et TEVA SANTE rappellent plusieurs lots de médicaments génériques contenant 20 mg d’oméprazole 2012-02-08
La AEMPS Advierte: Niveles Bajos de Magnesio Pueden Estar Asociados al Uso Prolongado de los Inhibidores de la Bomba de Protones 2012-01-02
TGA Continues to Receive Reports of Acute Interstitial Nephritis Caused by Proton Pump Inhibitors 2011-12-05
Low Magnesium Levels Can Be Associated With Long-Term Use of Proton Pump Inhibitors 2011-06-06
FDA Issues Update for Proton Pump Inhibitors and Risk of Fractures 2011-03-24
FDA Warns: Low Magnesium Levels Can Be Associated With Long-Term Use of Prescription Proton Pump Inhibitors 2011-03-02
FDA Updates Prescribing Information for Proton Pump Inhibitors to Warn About Increased Risk of Fractures 2010-05-26
Proton Pump Inhibitors (PPIs) May Be Linked to Bone Fractures and Bacterial Infections 2010-05-12
Proton Pump Inhibitors (PPIs) May Be Linked to Bone Fractures and Bacterial Infections 2010-05-12
Proton Pump Inhibitors (PPIs) in Healthy Patients May Cause Rebound Heartburn Symptoms 2009-09-16
Early Communication about Potential Drug Interaction Between PLAVIX and PROTON PUMP INHIBITORS 2008-11-13
Long-term use of proton pump inhibitors (PPIs) may increase risk of fractures 2008-09-18
Early Communication About an Ongoing Safety Review 2007-08-09

See alerts for all drugs